Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
UFP Industries
UFPI
$4.9B
| $791K | 0.03% |
49,152
-1,800
| -4% | -$30.3K |
|
302
Plexus
PLXS
$6.4B
| $790K | 0.03% |
18,239
+5,939
| +48% | +$248K |
|
303
Crown Castle
CCI
$32.1B
| $781K | 0.03% |
+10,522
| New | +$789K |
|
|
ANR
304
DELISTED
Alpha Natural Resources Inc
ANR
| $779K | 0.03% |
+210,000
| New | +$846K |
|
305
Boeing
BA
$169B
| $775K | 0.03% |
6,094
-2,725
| -31% | -$356K |
|
306
Telephone and Data Systems
TDS
$3.87B
| $774K | 0.03% |
29,660
-5,165
| -15% | -$137K |
|
307
LyondellBasell Industries
LYB
$21.8B
| $772K | 0.03% |
7,904
-177,880
| -96% | -$16.9M |
|
308
Gilead Sciences
GILD
$181B
| $771K | 0.03% |
9,304
-1,501
| -14% | -$117K |
|
|
OA
309
DELISTED
Orbital ATK, Inc.
OA
| $771K | 0.03% |
5,756
-3,144
| -35% | -$434K |
|
310
American Financial Group
AFG
$11.9B
| $769K | 0.03% |
12,910
-3,317
| -20% | -$193K |
|
|
QLGC
311
DELISTED
QLOGIC CORP
QLGC
| $769K | 0.03% |
76,239
+26,975
| +55% | +$289K |
|
312
Merck
MRK
$376B
| $767K | 0.03% |
13,903
+8,626
| +163% | +$471K |
|
313
CDW
CDW
$17.2B
| $766K | 0.03% |
24,024
+760
| +3% | +$22.3K |
|
|
OPWR
314
DELISTED
OPOWER INC COM STK (DE)
OPWR
| $766K | 0.03% |
+40,658
| New | +$758K |
|
|
BGFV
315
DELISTED
Big 5 Sporting Goods
BGFV
| $764K | 0.03% |
62,300
+30,327
| +95% | +$396K |
|
|
TCF
316
DELISTED
TCF Financial Corporation
TCF
| $764K | 0.03% |
46,677
+8,782
| +23% | +$141K |
|
|
CVSA
317
Covista Inc
CVSA
$4.51B
| $761K | 0.03% |
+17,962
| New | +$764K |
|
318
Synopsys
SNPS
$76.2B
| $760K | 0.03% |
19,582
+1,397
| +8% | +$53.3K |
|
|
WAIR
319
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $760K | 0.03% |
38,100
-9,344
| -20% | -$195K |
|
|
RKT
320
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $759K | 0.03% |
14,370
+8,798
| +158% | +$443K |
|
321
Reliance Steel & Aluminium
RS
$19.8B
| $755K | 0.03% |
10,245
-956
| -9% | -$68.7K |
|
|
ROC
322
DELISTED
ROCKWOOD HLDGS INC
ROC
| $755K | 0.03% |
9,931
+1,699
| +21% | +$125K |
|
323
Thermo Fisher Scientific
TMO
$233B
| $754K | 0.03% |
6,390
-2,745
| -30% | -$323K |
|
324
Jacobs Solutions
J
$17.6B
| $753K | 0.03% |
17,080
+6,078
| +55% | +$289K |
|
325
Sunstone Hotel Investors
SHO
$2.1B
| $753K | 0.03% |
+50,437
| New | +$723K |
|
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.